LavanyaBellumkondaMD

Echocardiography, Heart Failure & Transplantation, Non-Invasive Cardiology

Associate Professor, Internal Medicine, Yale University School of Medicine

Dr. Bellumkonda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
Arsalan Abu-Much, Cindy L Grines, Shmuel Chen, Wayne B Batchelor, Duzhi Zhao
International Journal of Cardiology. 2024-12-15
1 citations
Right Ventricular Dysfunction in Patients Undergoing High-Risk PCI with Impella.
Karl-Philipp Rommel, Guillaume Bonnet, Lavanya Bellumkonda, Alexandra J Lansky, Duzhi Zhao
Journal of Cardiac Failure. 2024-10-01
5 citations
Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.
Kiran Khush, Shelley Hall, Andrew Kao, Nirav Raval, Ravi Dhingra
The Journal of Heart and Lung Transplantation. 2024-09-01

Journal Articles

Role of Class I and Class II Panel Reactive Antibodies in Predicting Post-Heart Transplant Rejection and Survival in the Current Era
Lavanya Bellumkonda, MD, Journal of Cardiac Failure

Intra-Aortic Balloon Pumps Most Successful Within Hour of Cardiogenic ShockDecember 7th, 2018